InvestorsHub Logo
Followers 23
Posts 6907
Boards Moderated 0
Alias Born 12/06/2020

Re: None

Monday, 03/22/2021 5:22:02 AM

Monday, March 22, 2021 5:22:02 AM

Post# of 38
Matthew Watters, CEO of BC Craft, stated, “We are thrilled to announce the closing of the Acquisition and look forward to integrating Ava Pathways’ team into a newly formed psychedelic division within BC Craft that will focus on research and development, clinical trials, and product formulation using psilocybin, the active compound found in psychedelic mushrooms. We are elated that BC Craft will explore innovative opportunities to commercialize its psychedelic assets as the legal framework evolves and enthusiastic to be at the forefront of an industry with the potential to benefit millions of people worldwide.”